Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
BMC Cancer
|
October 17, 2015
Transarterial injection of recombinant human type-5 adenovirus H101 in combination with transarterial chemoembolization (TACE) improves overall and progressive-free survival in unresectable hepatocellular carcinoma (HCC)
Xiao-Jun Lin, Qi-Jiong Li, Xiang-Ming Lao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 22, 2022
Reply to J. Mei et al
Min-Ke He, Qi-Jiong Li, Zhi-Cheng Lai, et al.
Cancer Cell International
|
September 14, 2019
NAP1L1 is a prognostic biomarker and contribute to doxorubicin chemotherapy resistance in human hepatocellular carcinoma
Yong Le, Anna Kan, Qi-Jiong Li, et al.
Chinese Journal of Cancer
|
April 3, 2013
A modified radiofrequency ablation approach for treating distant lymph node metastasis in two patients with late-stage cancer
Ru-Hai Zou, Qi-Jiong Li, Ji-Liang Qiu, et al.
BMC Gastroenterology
|
June 22, 2019
Clinical practice of basin-shaped hepaticojejunostomy following hilar resection of stage III/IV hilar cholangiocarcinoma
Qi-Jiong Li, Zhong-Guo Zhou, Xiao-Jun Lin, et al.
Chinese Journal of Cancer
|
October 25, 2017
Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study
Min-Ke He, Yong Le, Qi-Jiong Li, et al.
Oncology Letters
|
February 14, 2018
Prognostic significance of sodium-potassium ATPase regulator, FXYD3, in human hepatocellular carcinoma
Li-Juan Wang, Qi-Jiong Li, Yong Le, et al.
Journal of Cancer
|
February 6, 2019
Transarterial Chemoembolization related to Good Survival for Selected Patients with advanced Hepatocellular Carcinoma
Yong Le, Jing-Xian Shen, Yong-Fa Zhang, et al.
Cardiovascular and Interventional Radiology
|
January 13, 2018
Phase II Study of Sorafenib Combined with Concurrent Hepatic Arterial Infusion of Oxaliplatin, 5-Fluorouracil and Leucovorin for Unresectable Hepatocellular Carcinoma with Major Portal Vein Thrombosis
Min-Ke He, Ru-Hai Zou, Qi-Jiong Li, et al.
Journal of Hepatocellular Carcinoma
|
April 1, 2021
Anti-PD-1 Immunotherapy Improves the Efficacy of Hepatic Artery Infusion Chemotherapy in Advanced Hepatocellular Carcinoma
Jie Mei, Shao-Hua Li, Qi-Jiong Li, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
BMC Cancer
|
October 17, 2015
Transarterial injection of recombinant human type-5 adenovirus H101 in combination with transarterial chemoembolization (TACE) improves overall and progressive-free survival in unresectable hepatocellular carcinoma (HCC)
Xiao-Jun Lin, Qi-Jiong Li, Xiang-Ming Lao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 22, 2022
Reply to J. Mei et al
Min-Ke He, Qi-Jiong Li, Zhi-Cheng Lai, et al.
Cancer Cell International
|
September 14, 2019
NAP1L1 is a prognostic biomarker and contribute to doxorubicin chemotherapy resistance in human hepatocellular carcinoma
Yong Le, Anna Kan, Qi-Jiong Li, et al.
Chinese Journal of Cancer
|
April 3, 2013
A modified radiofrequency ablation approach for treating distant lymph node metastasis in two patients with late-stage cancer
Ru-Hai Zou, Qi-Jiong Li, Ji-Liang Qiu, et al.
BMC Gastroenterology
|
June 22, 2019
Clinical practice of basin-shaped hepaticojejunostomy following hilar resection of stage III/IV hilar cholangiocarcinoma
Qi-Jiong Li, Zhong-Guo Zhou, Xiao-Jun Lin, et al.
Chinese Journal of Cancer
|
October 25, 2017
Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study
Min-Ke He, Yong Le, Qi-Jiong Li, et al.
Oncology Letters
|
February 14, 2018
Prognostic significance of sodium-potassium ATPase regulator, FXYD3, in human hepatocellular carcinoma
Li-Juan Wang, Qi-Jiong Li, Yong Le, et al.
Journal of Cancer
|
February 6, 2019
Transarterial Chemoembolization related to Good Survival for Selected Patients with advanced Hepatocellular Carcinoma
Yong Le, Jing-Xian Shen, Yong-Fa Zhang, et al.
Cardiovascular and Interventional Radiology
|
January 13, 2018
Phase II Study of Sorafenib Combined with Concurrent Hepatic Arterial Infusion of Oxaliplatin, 5-Fluorouracil and Leucovorin for Unresectable Hepatocellular Carcinoma with Major Portal Vein Thrombosis
Min-Ke He, Ru-Hai Zou, Qi-Jiong Li, et al.
Journal of Hepatocellular Carcinoma
|
April 1, 2021
Anti-PD-1 Immunotherapy Improves the Efficacy of Hepatic Artery Infusion Chemotherapy in Advanced Hepatocellular Carcinoma
Jie Mei, Shao-Hua Li, Qi-Jiong Li, et al.
Page
of 2